Mark Wappett Selected Research

Enzymes

1/2020

Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Wappett Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2016
2	Disease Progression 07/2015 - 05/2015
1	Rare Diseases (Rare Disease) 05/2012
1	Fanconi Anemia (Fanconi's Anemia) 06/2011

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2012
2	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 01/2022 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 07/2015
1	Calcibiotic Root Canal SealerIBA 03/2022
1	Caspase 8 (Caspase-8)IBA 01/2022
1	EnzymesIBA 01/2020
1	entinostat (MS 275)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	nutlin 3IBA 01/2020
1	pevonedistatIBA 01/2020
1	SolutionsIBA 04/2016
1	RNA (Ribonucleic Acid)IBA 04/2016
1	Biological ProductsIBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	LeptinIBA 01/2016
1	cediranib (AZD2171)IBA 01/2016
1	ParaffinIBA 07/2015
1	Formaldehyde (Formol)FDA Link 07/2015
1	carboxyl radical (COO-)IBA 05/2015
1	fostamatinibIBA 05/2015
1	telomerase RNA (bTR)IBA 06/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 01/2016
1	Therapeutics 01/2016